Strata Skin Sciences Inc recently announced a successful amendment to its credit agreement with MidCap Financial, which amends certain financial covenants to enhance liquidity and financial flexibility. This move ensures alignment with the company’s current and future business operations.
Despite a net increase in Strata Skin Sciences Inc recently announced a successful amendment to its credit agreement with MidCap Financial, which amends certain financial covenants to enhance liquidity and financial flexibility. This move ensures alignment with the company’s current and future business operations. "https://csimarket.com/stocks/at_glance.php?code=SSKN">SSKN">borrowings by -19.05% in the third quarter of 2023, Strata Skin Sciences Inc managed to enhance its Leverage Ratio to 1.91, surpassing the company’s average. In comparison to 155 other companies within the industry, Strata Skin Sciences Inc reported a higher Leverage Ratio in the third quarter of 2023.
However, the company’s position in terms of Leverage Ratio has deteriorated from 2.26 in the second quarter of 2023 to 2.97. Nonetheless, when considering the trailing twelve months Leverage Ratio and repayments of liabilities, Strata Skin Sciences Inc’s ratio improved to 1.74, which is also the lowest in the industry.
Despite the decline in its overall ranking for the trailing twelve months Leverage Ratio, Strata Skin Sciences Inc’s successful amendment to its credit agreement with MidCap Financial showcases its commitment to enhancing financial flexibility and ensuring the company’s continued success in the industry.
Comments